Cyntegrity | Data Science for Clinical Trials
Follow Us on LinkedIn

Responsible AI
in Clinical Trials

Stay informed with AI industry insiders! Register for the FREE 2nd annual virtual summit on October 8 and 9, 2024.

Thank you! Your registration has been successfully submitted. You will receive a personal invite with a webinar link within 1-2 days.

Returning and New Powerhouses

Building on last year's success, leading voices from top organizations have confirmed their participation as speakers for this year's summit. Don't miss their valuable insights.

Tufts CSDD
AI Futurescape

From Bots to Trusted Agents:
Ensuring Validity in AI for Clinical Trials

AI in clinical trials is advancing from basic tools to sophisticated agents, making validation and reliability more crucial than ever. This summit will gather expertise to address concerns about AI accuracy, particularly in Decision Support Systems and Predictive Modeling, and explore effective, responsible integration into clinical trials through real-world applications and emerging trends.

We are proud to introduce a diverse range of speakers for the 2024 summit:

Linda Sullivan, Senior Fellow at Tufts Center for the Study of Drug Development

Linda Sullivan

Senior Fellow
at Tufts Center for the Study
of Drug Development
Andrzej Kinasiewicz, Director, Centralized Monitoring at AstraZeneca

Dr Andrzej Kinasiewicz

Director,
Centralized Monitoring
at Astra Zeneca
Wole Moses, Sr Dir US Federal Growth Strategy at Microsoft

Wole Moses

Chief AI Officer
at Microsoft
Federal Civilian
Mariana Hebborn PhD, Global Head of HR AI & Data Governance at Merck

Dr Mariana Hebborn

Global Head of HR AI
& Data Governance
at Merck
Danny Goh, Founder and CEO of Nexus FrontierTech

Danny Goh

Founder & CEO
at Nexus FrontierTech,
co-author The AI Republic
Jessica Cordes, Senior Consultant and Trainer at Clinical Excellence

Jessica Cordes

Senior Consultant
and Trainer
at Clinical Excellence
Nechama Katan, Dir Innovative Data Analytics at Pfizer

Nechama Katan

Director Innovative
Data Analytics
at Pfizer
Dr Mary Jo Lamberti, Associate Director and Research Assistant Professor at Tufts CSDD

Dr Mary Jo Lamberti

Research Associate Professor and
Director of Sponsored Research
at Tufts CSDD
Sigrid Berge van Rooijen, AI Business Consultant at Eir Health

Sigrid Berge
van Rooijen

AI Business Consultant
at Eir Health
Ron Burns, SME for AI in Clinical Trials

Ron Burns

Subject Matter Expert
in AI for Clinical Trials,
Biofourmis
Kanchana Iyer, Sr. Consultant, Regulatory Affairs at Halloran

Kanchana Iyer

Sr Consultant,
Regulatory Affairs
at Halloran
Meghan Patterson, Associate Principal Consultant at Halloran

Meghan Patterson

Associate
Principal Consultant
at Halloran
Patrick Risch, Partner | Risk Consulting at EY

Patrick Risch

Partner Risk Consulting
Digitalization & Technology
at EY
Nurcan Coskun, Former Global Head of RBQM at Medtronic

Nurcan Coskun

Former Global Head
of RBQM
at Medtronic
Dr. Lakkavallia AI Master MIT Sloan School Management

Dr Lakkavalli Amrith

AI Master
Tech Advocate
at Fortrea
Artem Andrianov, PhD, CEO & Founder at Cyntegrity

Artem Andrianov, PhD

Chief Executive Officer
& Founder
at Cyntegrity
Event Details

Event Details

We look forward to your participation in this community-building, free event, shaping the responsible use of AI in clinical trials.

For any questions or additional details please reach out to Tamara Beck, our MyRBQM Academy Operations Manager, at:

Event Dates

Dates

October 8 & 9, 2024

Event Time

Time

15:00 - 17:30 CEST | 9:00 AM - 11:30 AM EDT

Event Format

Format

Virtual, 2 webinars of 2.5 hours each

Preliminary Agenda

Virtual Summit Program

Spreading over two days with sessions lasting 2.5 hours each, this free event aims to foster meaningful dialogue on Responsible AI in clinical trials.

DAY 1 | TUESDAY, OCTOBER 8

  • Introduction & Welcome Remarks - Event objectives & the importance of AI in clinical trials
  • AI as an Assistant - What are the practical applications of AI as an assistant, and how can it be supervised effectively to ensure accurate and reliable outcomes?
  • Bias and Fairness - AI is only as unbiased as its data. How can we identify and mitigate biases in AI algorithms used in clinical trials, and what steps can be taken to ensure these models are fair and unbiased?
  • Building Trust and Driving Adoption (Stakeholder and Panel Discussion) - Strategies for integrating validated AI into clinical trials: Explore how to build trust, manage change, and engage stakeholders in adopting AI technologies that are reliable and validated.
  • Q/A & Closing Remarks

DAY 2 | WEDNESDAY, OCTOBER 9

  • Recap Day 1 - Insights & Observations
  • Real-World Applications of Trusted AI - What are some successful case studies of validated AI implementation in clinical trials, and what lessons can be learned from these to guide future AI projects?
  • Navigating AI Legislation - We will examine the latest regulatory updates and guidelines for AI in clinical trials and how organizations can ensure compliance while maintaining the validity and trustworthiness of AI-augmented systems.
  • Future Trends (Stakeholder and Panel Discussion) - What are the emerging trends in AI technology that could impact clinical trials, and how can organizations stay ahead of the curve and prepare for future AI advancements?
  • Q/A & Closing Remarks - Summary & next steps for Responsible AI

Who Should Join the Dialogue?

Directors and Senior Managers specializing in: Clinical Operations & Study Management, Innovation & New Technologies, Clinical Monitoring & Site Management, Project & Program Management

Heads of Therapeutic Areas and Medical Affairs

Functional Leads in Data Management and Biostatistics

Compliance and Quality Assurance Officers

Regulatory Affairs Executives

Artem Andrianov, Co-founder & CEO of Cyntegrity

We're on the verge of a new era in clinical trials, where AI processes data and understands human emotions and preferences.

Let's leverage AI's power to create a future where technology and humanity collaborate to improve healthcare outcomes.

Artem Andrianov, PhD

CEO & Founder of Cyntegrity

Got 10 Minutes?

How do you see the future of AI in clinical trials? Help us understand the impact of AI in clinical trials.

AI-Augmented RBQM Solutions

©2024 Cyntegrity - All Rights Reserved

Cyntegrity | Data Science for Clinical Trials